Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
FDA accepts new drug application, prioritizes review for potential Stargardt treatment
4 minutes
Posted Aug 14, 2026 at 6:43 pm.
0:00
4:30
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Belite Bio’s tinlarebant could become the first-ever approved treatment for Stargardt disease
Previous
Eye on the Cure Podcast | Episode 102: What is Venture Philanthropy?
Next
PRIMA retinal implant restores sight in patients with geographic atrophy from AMD
← See all 275 episodes of Foundation Fighting Blindness